Paolo Verderio
Overview
Explore the profile of Paolo Verderio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
1533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cas M, Ciniselli C, Vergani E, Ciusani E, Aloisi M, Duroni V, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338838
Dysfunctions of lipid metabolism are associated with tumor progression and treatment resistance of cutaneous melanoma. BRAF/MEK inhibitor resistance is linked to alterations of melanoma lipid pathways. We evaluated whether a...
12.
Boeri M, Signoroni S, Ciniselli C, Gariboldi M, Zanutto S, Rausa E, et al.
Cancer Gene Ther
. 2024 Feb;
31(6):842-850.
PMID: 38332046
Lynch syndrome (LS) is an inherited condition characterized by an increased risk of developing cancer, in particular colorectal cancer (CRC). Microsatellite instability (MSI) is the main feature of (pre)cancerous lesions...
13.
Di Cosimo S, Pizzamiglio S, Ciniselli C, Duroni V, Cappelletti V, De Cecco L, et al.
Sci Rep
. 2024 Jan;
14(1):2628.
PMID: 38297001
In clinical trials evaluating antibody-conjugated drugs (ADCs), HER2-low breast cancer is defined through protein immunohistochemistry scoring (IHC) 1+ or 2+ without gene amplification. However, in daily practice, the accuracy of...
14.
Gronchi A, Palmerini E, Quagliuolo V, Broto J, Lopez Pousa A, Grignani G, et al.
J Clin Oncol
. 2024 Jan;
42(8):898-906.
PMID: 38232337
Purpose: A randomized trial was conducted to compare neoadjuvant standard (S) anthracycline + ifosfamide (AI) regimen with histology-tailored (HT) regimen in selected localized high-risk soft tissue sarcoma (STS). The results...
15.
Rausa E, Ciniselli C, Signoroni S, Boer L, Oldhoff L, Dijk L, et al.
Int J Colorectal Dis
. 2023 Oct;
38(1):249.
PMID: 37804449
Purpose: Colorectal adenomatous polyposis is characterized by the onset of tens to thousands of adenomas in the colorectal epithelium and, if not treated, leads to a lifetime increased risk of...
16.
Sala L, Ciniselli C, Bozzi F, Summo V, Bonini C, Brich S, et al.
Tumori
. 2023 Aug;
110(1):49-59.
PMID: 37574933
Introduction: The synthesis of the periprosthetic capsule during implant-based breast reconstruction is the result of a coordinate cascade of inflammatory events ending in a fibrous tissue deposition around the expander...
17.
Colletti G, Ciniselli C, Sorrentino L, Bagatin C, Verderio P, Cosimelli M
Dig Liver Dis
. 2023 Jun;
55(12):1602-1610.
PMID: 37277288
Background: Specific studies on stage IV rectal cancer are lacking. The aim of this study is to describe the current status of rectum-first approach (RFA), liver-first approach (LFA) and simultaneous...
18.
Di Cosimo S, Ciniselli C, Pizzamiglio S, Cappelletti V, Silvestri M, El-Abed S, et al.
Front Oncol
. 2023 Feb;
12:1028825.
PMID: 36798690
Background: The absence of breast cancer cells in surgical specimens, , pathological complete response (pCR), is widely recognized as a favorable prognostic factor after neoadjuvant therapy. In contrast, the presence...
19.
Peritoneal fluid COVID-19 testing in patients with a negative nasopharyngeal swab: prospective study
Licata A, Ciniselli C, Sorrentino L, Micali A, Daidone M, Guaglio M, et al.
Br J Surg
. 2023 Feb;
110(4):504-505.
PMID: 36726208
No abstract available.
20.
Verderio P, Lecchi M, Ciniselli C, Shishmani B, Apolone G, Manenti G
Animals (Basel)
. 2023 Jan;
13(2).
PMID: 36670818
Animal experimentation is a vast ecosystem that tries to make different issues such as legislative, ethical and scientific coexist. Research in animal experimentation has made many strides thanks to the...